Alphabet Inc. - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 42 filers reported holding EVELO BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Alphabet Inc. ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$190,889
-88.8%
1,060,4950.0%0.01%
-88.9%
Q4 2022$1,707,397
-23.0%
1,060,4950.0%0.10%
-12.4%
Q3 2022$2,216,000
-1.0%
1,060,4950.0%0.11%
-6.6%
Q2 2022$2,238,000
-37.7%
1,060,4950.0%0.12%
+3.4%
Q1 2022$3,595,000
-44.2%
1,060,4950.0%0.12%
-24.5%
Q4 2021$6,437,000
-13.8%
1,060,4950.0%0.16%
-12.4%
Q3 2021$7,466,000
-48.8%
1,060,4950.0%0.18%
-40.4%
Q2 2021$14,571,000
+28.4%
1,060,4950.0%0.30%
-35.0%
Q1 2021$11,347,000
-11.5%
1,060,4950.0%0.46%
-25.7%
Q4 2020$12,821,000
+129.4%
1,060,4950.0%0.62%
+133.8%
Q3 2020$5,589,000
+7.6%
1,060,4950.0%0.26%
+9.6%
Q2 2020$5,196,000
+30.5%
1,060,4950.0%0.24%
-8.0%
Q1 2020$3,982,000
-7.5%
1,060,4950.0%0.26%
+0.4%
Q4 2019$4,306,000
-33.4%
1,060,4950.0%0.26%
+34.0%
Q3 2019$6,469,000
-32.1%
1,060,4950.0%0.19%
+7.2%
Q2 2019$9,523,000
+12.2%
1,060,4950.0%0.18%
-58.7%
Q1 2019$8,484,000
-38.5%
1,060,4950.0%0.44%
-73.1%
Q4 2018$13,797,000
+6.8%
1,060,4950.0%1.63%
+31.9%
Q3 2018$12,917,000
+3.2%
1,060,4950.0%1.24%
+17.7%
Q2 2018$12,514,0001,060,4951.05%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Mayo Clinic 479,242$6,585,0007.28%
Flagship Pioneering Inc. 23,030,069$316,433,0004.04%
HARBOURVEST PARTNERS LLC 3,063,505$42,093,0004.02%
Trustees of Columbia University in the City of New York 113,850$1,564,0002.31%
Alphabet Inc. 1,060,495$14,571,0000.30%
Artal Group S.A. 1,000,000$13,740,0000.28%
Larson Financial Group LLC 31,354$431,0000.10%
Virtus ETF Advisers LLC 13,690$188,0000.08%
STATE OF MICHIGAN RETIREMENT SYSTEM 900,000$12,366,0000.07%
CREDIT SUISSE AG/ 3,095,719$42,536,0000.02%
View complete list of EVELO BIOSCIENCES INC shareholders